Loading...
Sanofi
SNYNF•PNK
Healthcare
Drug Manufacturers - General
$92.79
$0.23(0.25%)
Sanofi (SNYNF) Financial Performance & Income Statement Overview
Review Sanofi (SNYNF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-3.80%
↓ 3.80%
Operating Income Growth
-7.91%
↓ 7.91%
Net Income Growth
2.96%
↑ 2.96%
Operating Cash Flow Growth
-11.47%
↓ 11.47%
Operating Margin
20.69%
↑ 20.69%
Gross Margin
67.96%
↑ 67.96%
Net Profit Margin
13.86%
↑ 13.86%
ROE
9.95%
↑ 9.95%
ROIC
11.13%
↑ 11.13%
Sanofi (SNYNF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Sanofi SNYNF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $10.61B | $7.63B | $14.16B | $11.38B |
| Cost of Revenue | $2.89B | $2.27B | $4.08B | $3.39B |
| Gross Profit | $7.72B | $5.36B | $10.07B | $7.99B |
| Gross Profit Ratio | $0.73 | $0.70 | $0.71 | $0.70 |
| R&D Expenses | $1.81B | $2.12B | $1.85B | $1.72B |
| SG&A Expenses | $2.22B | $1.24B | $2.68B | $2.69B |
| Operating Expenses | $5.43B | $4.79B | $6.44B | $6.63B |
| Total Costs & Expenses | $8.32B | $7.06B | $10.52B | $10.02B |
| Interest Income | $86.00M | $0.00 | $133.00M | $56.00M |
| Interest Expense | $213.00M | $0.00 | $265.00M | $135.00M |
| Depreciation & Amortization | $399.00M | $209.00M | $479.00M | $882.00M |
| EBITDA | $2.77B | $563.00M | $4.25B | $2.51B |
| EBITDA Ratio | $0.26 | $0.07 | $0.30 | $0.22 |
| Operating Income | $2.29B | $573.00M | $3.63B | $1.63B |
| Operating Income Ratio | $0.22 | $0.08 | $0.26 | $0.14 |
| Other Income/Expenses (Net) | -$127.00M | -$117.00M | -$132.00M | -$179.00M |
| Income Before Tax | $2.16B | $456.00M | $3.50B | $1.42B |
| Income Before Tax Ratio | $0.20 | $0.06 | $0.25 | $0.12 |
| Income Tax Expense | $481.00M | $4.00M | $737.00M | $299.00M |
| Net Income | $1.87B | $499.00M | $2.81B | $1.11B |
| Net Income Ratio | $0.18 | $0.07 | $0.20 | $0.10 |
| EPS | $1.52 | $0.54 | $2.25 | $0.89 |
| Diluted EPS | $1.52 | $0.54 | $2.25 | $0.89 |
| Weighted Avg Shares Outstanding | $1.23B | $1.25B | $1.25B | $1.25B |
| Weighted Avg Shares Outstanding (Diluted) | $1.23B | $1.25B | $1.25B | $1.25B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan